Investing Ideas
Browse All Stocks
Markets
Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Investing Ideas
›
Mid-Large Cap Stocks
Edit Screener
Get New Stock Alert
Mid-Large Cap Stocks
Results
229
3 new
Mid-Large Cap Stocks
🇺🇸 US Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
229 companies
3 new companies last 7d
Company
Last Price
7D Return
1Y Return
Market Cap
Analysts Target
Valuation
Growth
Div Yield
JNJ
Johnson & Johnson
US$267.28
0.07%
50.8%
US$643.9b
US$277.91
PE
30.6
S
7.9%
2.0%
BMY
Bristol-Myers Squibb
US$63.60
-1.3%
37.8%
US$130.2b
US$66.71
PE
14.0
E
-6.9%
4.0%
ZTS
Zoetis
US$73.00
-0.4%
-50.3%
US$30.3b
US$96.00
PE
11.4
E
3.5%
2.9%
AMGN
Amgen
US$376.35
-3.8%
37.0%
US$203.1b
US$388.03
PE
23.3
E
7.5%
2.7%
PFE
Pfizer
US$27.46
-1.2%
14.2%
US$157.0b
US$28.88
PE
36.1
E
8.0%
6.3%
MRK
Merck
US$144.91
-1.8%
78.6%
US$354.8b
US$152.96
PE
112.7
E
31.9%
2.3%
ABBV
AbbVie
US$262.51
4.6%
18.9%
US$464.8b
US$278.61
PE
74.0
E
23.7%
2.6%
GILD
Gilead Sciences
US$147.68
2.0%
30.0%
US$183.1b
US$158.15
PS
6.0
E
45.4%
2.2%
PRGO
Perrigo
US$13.54
-5.6%
-35.9%
US$1.9b
US$16.50
PS
0.5
E
85.2%
8.6%
QGEN
Qiagen
US$42.90
0.9%
-10.3%
US$8.8b
US$46.27
PE
21.7
E
11.0%
6.4%
DHR
Danaher
US$208.36
1.7%
8.0%
US$147.2b
US$229.09
PE
36.7
E
14.1%
0.8%
PAHC
Phibro Animal Health
US$35.30
-4.1%
-8.5%
US$1.4b
US$44.00
PE
14.4
E
14.6%
1.4%
RPRX
Royalty Pharma
US$58.47
-3.5%
64.1%
US$33.6b
US$65.13
PE
32.1
E
15.9%
1.6%
VTRS
Viatris
US$17.02
3.2%
76.9%
US$19.1b
US$18.78
PS
1.3
E
46.1%
2.8%
ANAB
AnaptysBio
US$54.31
-2.5%
174.2%
US$1.6b
US$89.63
PS
6.9
E
46.9%
41.4%
DNTH
Dianthus Therapeutics
US$102.49
-4.3%
163.6%
US$5.9b
US$140.80
PS
3010.9
E
24.8%
n/a
NRIX
Nurix Therapeutics
US$25.15
-4.2%
193.5%
US$2.6b
US$33.93
PS
71.0
E
-14.5%
n/a
TRVI
Trevi Therapeutics
US$15.01
-9.8%
88.1%
US$2.1b
US$28.18
PB
6.7
E
-4.1%
n/a
AMPH
New
Amphastar Pharmaceuticals
US$23.95
3.9%
-11.2%
US$1.0b
US$22.50
PE
13.0
E
6.3%
n/a
STVN
Stevanato Group
US$22.53
11.3%
-16.3%
US$5.9b
US$24.68
PE
39.8
E
18.4%
0.3%
URGN
UroGen Pharma
US$43.49
-3.4%
140.3%
US$2.0b
US$60.00
PS
11.3
E
54.8%
n/a
AMLX
Amylyx Pharmaceuticals
US$32.63
0.7%
155.5%
US$4.2b
US$42.36
PB
17.1
E
64.6%
n/a
ATTO
Attovia Therapeutics
US$22.25
-2.7%
n/a
US$1.1b
US$42.20
PS
564.3
E
-27.8%
n/a
RCUS
Arcus Biosciences
US$24.65
-13.5%
104.9%
US$3.1b
US$38.75
PS
26.8
E
35.8%
n/a
Page 1 of 7